SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-024003
Filing Date
2024-03-19
Accepted
2024-03-19 16:01:13
Documents
16
Period of Report
2024-03-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0202009-8k_longeveron.htm   iXBRL 8-K 31522
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF LONGEVERON INC. ea020200901ex3-1a_longeveron.htm EX-3.1(A) 13974
3 PRESS RELEASE DATED MARCH 19, 2024 ea020200901ex99-1_longeveron.htm EX-99.1 15597
7 GRAPHIC ex99-1_001.jpg GRAPHIC 12136
  Complete submission text file 0001213900-24-024003.txt   265900

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lgvn-20240319.xsd EX-101.SCH 3021
5 XBRL LABEL FILE lgvn-20240319_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE lgvn-20240319_pre.xml EX-101.PRE 22363
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0202009-8k_longeveron_htm.xml XML 3837
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 24762896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)